Recent advances in multicolor flow cytometry, such as (i) the increase in the number of detection channels, (ii) the development of more user-friendly software for both instrumentation and analysis ...

Seeking ways to improve the safety of anti-amyloid antibodies, John Sims of Eli Lilly & Company presented a simple option to do so for donanemab at this year’s Clinical Trials on Alzheimer’s Disease ...